Hereditary transthyretin amyloidosis: baseline characteristics of patients in the NEURO-TTR trial

Marcia Waddington-CruzDepartment of Neurology, Hospital Universitario Clementino Fraga, Federeal University of Rio, Rio de Janeiro, Brazil; View further author information

Elizabeth J. AckermannClinical Development, Ionis Pharmaceuticals, Carlsbad, California, USA; View further author information

Michael PolydefkisDepartment of Neurology, Johns Hopkins University, Baltimore, Maryland, USA; View further author information

Stephen B. HeitnerDivision of Cardiovascular Medicine, Knight Cardiovascular Institute, Portland, Oregon, USA; View further author information

Peter J. DyckDepartment of Neurology, Mayo Clinic, Rochester, Minnesota, USA; View further author information

Fabio A. BarrosoDepartment of Neurology, Institute for Neurological Research Raúl Carrea, FLENI, Buenos Aires, Argentina; View further author information

Annabel K. WangDepartment of Neurology, University of California, Irvine, Orange, California, USA; View further author information

John L. BerkAmyloidosis Center, Boston University School of Medicine, Boston, Massachusetts, USA;

P. James B. DyckDepartment of Neurology, Mayo Clinic, Rochester, Minnesota, USA; View further author information

Brett P. MoniaDrug Discovery, Ionis Pharmaceuticals, Carlsbad, California, USA; View further author information

Steven G. HughesClinical Development, Ionis Pharmaceuticals, Carlsbad, California, USA; View further author information

Li TaiClinical Development, Ionis Pharmaceuticals, Carlsbad, California, USA; View further author information

T. Jesse KwohClinical Development, Ionis Pharmaceuticals, Carlsbad, California, USA; View further author information

Shiangtung W. JungBiometrics, Ionis Pharmaceuticals, Carlsbad, California, USA; View further author information

Teresa CoelhoHospital de Santo Antonio, Centro Hospitalar Porto, Porto, Portugal; View further author information

Merrill D. BensonDepartment of Pathology and Laboratory Medicine, Indiana University School of Medicine, Indianapolis, Indiana, USA; View further author information

Morie A. GertzDivision of Hematology, Mayo Clinic, Rochester, Minnesota, USACorrespondence[email protected]

Related Research Data